Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Denintuzumab (Anti-CD19) For research use only.
Not for use in humans.

Denintuzumab (Anti-CD19)

Synonyms: hBU 12

Denintuzumab (anti-CD19) is a recombinant humanized anti-CD19 monoclonal antibody that can be used in the research of acute lymphoblastic leukemia. Denintuzumab can be used to synthesize ADC antibody Denintuzumab Mafodotin (SGN-CD19A). MW: 145.0 kD.

Denintuzumab (Anti-CD19)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Denintuzumab (anti-CD19) is a recombinant humanized anti-CD19 monoclonal antibody that can be used in the research of acute lymphoblastic leukemia. Denintuzumab can be used to synthesize ADC antibody Denintuzumab Mafodotin (SGN-CD19A). MW: 145.0 kD.

Product Details

CAS No. 1630074-14-4
Molecular Weight 145
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Denintuzumab (Anti-CD19) | Denintuzumab (Anti-CD19) supplier | purchase Denintuzumab (Anti-CD19) | Denintuzumab (Anti-CD19) cost | Denintuzumab (Anti-CD19) manufacturer | order Denintuzumab (Anti-CD19) | Denintuzumab (Anti-CD19) distributor